Tailin Biotech (300813.SZ) announced results for the first three quarters, with net profit of RMB 28.773 million to mother, an increase of 90.70% over the previous year

According to the Zhitong Finance App, Tailin Biotech (300813.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 255 million yuan, an increase of 19.58% over the previous year. Net profit attributable to shareholders of listed companies was RMB 28.773 million, a year-on-year increase of 90.70%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 21.32,500, an increase of 63.41% over the previous year.